EP 1204434 A1 20020515 - TISSUE AUGMENTATION MATERIAL AND METHODS
Title (en)
TISSUE AUGMENTATION MATERIAL AND METHODS
Title (de)
MATERIAL UND VERFAHREN ZUR VERMEHRUNG VON GEWEBE
Title (fr)
PROCEDE ET MATERIAU POUR L'AUGMENTATION DES TISSUS
Publication
Application
Priority
- US 0022247 W 20000811
- US 14859099 P 19990813
Abstract (en)
[origin: WO0112247A1] A permanent, biocompatible material for soft tissue augmentation. The biocompatible material comprises a matrix of smooth, round, finely divided, substantially spherical particles of a biocompatible ceramic material, close to or in contact with each other, which provide a scaffold or lattice for autogenous, three dimensional, randomly oriented, non-scar soft tissue growth at the augmentation site. The augmentation material can be homogeneously suspended in a biocompatible, resorbable lubricious gel carrier comprising a polysaccharide. This serves to improve the delivery of the augmentation material by injection to the tissue site where augmentation is desired. The augmentation material is especially suitable for urethral sphincter augmentation, for treatment of incontinence, for filling soft tissue voids, for creating soft tissue blebs, for the treatment of unilateral vocal cord paralysis, and for mammary implants. It can be injected intradermally, subcutaneously or can be implanted.
[origin: WO0112247A1] A permanent, biocompatible material for soft tissue augmentation. The biocompatible material comprises a matrix of smooth, round, finely divided, substantially spherical particles of a biocompatible ceramic material, close to or in contact with each other, which provide a scaffold or lattice for autogenous, three dimensional, randomly oriented, non-scar soft tissue growth at the augmentation site. The augmentation material can be homogeneously suspended in a biocompatible, resorbable lubricious gel carrier comprising a polysaccharide. This serves to improve the delivery of the augmentation material by injection to the tissue site where augmentation is desired. The augmentation material is especially suitable for urethral sphincter augmentation, for treatment of incontinence, for filling soft tissue voids, for creating soft tissue blebs, for the treatment of unilateral vocal cord paralysis, and for mammary implants. It can be injected intradermally, subcutaneously or can be implanted.
IPC 1-7
IPC 8 full level
A61K 47/36 (2006.01); A61K 31/74 (2006.01); A61K 33/06 (2006.01); A61K 33/10 (2006.01); A61K 33/24 (2006.01); A61K 47/10 (2006.01); A61K 47/38 (2006.01); A61L 27/00 (2006.01); A61L 27/46 (2006.01); A61L 27/50 (2006.01)
CPC (source: EP KR)
A61L 27/46 (2013.01 - EP KR); A61L 27/50 (2013.01 - EP KR); C04B 35/447 (2013.01 - EP); C04B 35/636 (2013.01 - EP); C04B 35/6365 (2013.01 - EP)
Citation (search report)
See references of WO 0112247A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0112247 A1 20010222; WO 0112247 A9 20020912; AU 6905100 A 20010313; BR 0013141 A 20020917; CA 2380932 A1 20010222; CN 1370084 A 20020918; EP 1204434 A1 20020515; HK 1047250 A1 20030214; JP 2003507351 A 20030225; KR 20020043557 A 20020610; MX PA02001613 A 20030721; TW 434006 B 20010516
DOCDB simple family (application)
US 0022247 W 20000811; AU 6905100 A 20000811; BR 0013141 A 20000811; CA 2380932 A 20000811; CN 00811750 A 20000811; EP 00957430 A 20000811; HK 02108296 A 20021115; JP 2001516589 A 20000811; KR 20027001944 A 20020214; MX PA02001613 A 20000811; TW 89116260 A 20000811